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A B S T R A C T
Aim: This study evaluated the efﬁcacy and tolerability of the ketogenic diet (KD) in young Indian children
with refractory epilepsy. The changes in biochemical and lipid proﬁle with KD were also assessed.
Methods: Children aged 6months to 5 years who had daily seizures (or at least 7 seizures/week) despite
the appropriate use of at least three antiepileptic drugs were enrolled. KD was introduced using a non-
fasting gradual initiation protocol. Seizure frequency, biochemical proﬁle (liver and kidney function
tests, fasting lipid proﬁle, and spot urinary calcium–creatinine ratio) and adverse effects were recorded.
Patients continuing KD were followed up for a minimum period of 12 months.
Results: Twenty-seven children were enrolled. Non-fasting gradual KD initiation was well tolerated.
Eighty-eight percent remained on KD at 3 months, 55% remained on KD at 6 months, and 37% remained
on it at 1 year. Intention-to-treat analysis revealed that 48% (13 of 27) had >50% reduction in seizures,
and four children (15 %) were seizure free at 6months. At 1 year, 37% had>50% reduction in seizures and
ﬁve children (18.5%) were seizure free. Adverse effects included constipation (74%), weight loss (14.8%),
edema due to hypo-albuminemia (7.4%) and renal stones (3.7%). Biochemical proﬁle did not reveal
signiﬁcant changes over time, except for reduced serum albumin and increased spot urinary calcium–
creatinine ratio.
Conclusion: KD is an effective and well-tolerated treatment option in young Indian children with
refractory epilepsy. However, careful ongoing medical supervision is needed.
 2009 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Several severe catastrophic epilepsies such asWest syndrome,
Lennox-Gastaut syndrome and myoclonic-astatic epilepsy pre-
sent in infants and young children. Seizures in these disorders are
difﬁcult to control; sometimes only at the expense of multiple
and toxic levels of antiepileptic medications. Epilepsy surgery is
not a very beneﬁcial option in this group. The shortcomings of
antiepileptic drug therapy and epilepsy surgery have led to the
need for alternative treatments. Ketogenic diet (KD) is a
medically supervised high fat, low carbohydrate diet that
maintains a chronic state of ketosis while providing proteins
and calories for adequate growth.1 The reported effectiveness of
KD matches or exceeds that of antiepileptic drugs (AED) in many
cases. Past studies have shown that at least 40–50% of children
with epilepsy have more than a 50% reduction in seizures when
on KD.1–8* Corresponding author. Tel.: +91 11 26593209; fax: +91 11 26588641.
E-mail address: sheffaligulati@gmail.com (S. Gulati).
1 Present address: Indraprastha Apollo Hospitals, New Delhi, India.
1059-1311/$ – see front matter  2009 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2009.04.001There is paucity of data on the usefulness of KD in Indian children
withepilepsy.Perceiveddifﬁculties includedoubtful acceptability in
a predominantly vegetarian population, unavailability of labelled
foods, and unfamiliarity of dieticians with KD. Therefore, this study
was planned to assess the feasibility, efﬁcacy, and tolerability of KD
in young Indian children with refractory epilepsy. We also assessed
the changes in biochemical and lipid proﬁle with KD.
2. Methods
2.1. Patient selection
This prospective open label, uncontrolled, study was conducted
in the Pediatric Department of a tertiary care hospital between
September 2006 and April 2008. Ethical approval by the
institutional ethics committee was obtained. Written informed
consent was obtained from the parents. Children aged 6months to
5 years who had at least 1 seizure/day or 7 seizures/week despite
the appropriate use of at least three antiepileptic drugs (AED)
including one newer AED were enrolled. Children with known or
suspected inborn errors of metabolism, systemic illness, or
surgically remediable causes of epilepsy were excluded.vier Ltd. All rights reserved.
Fig. 1. Flow of patients in the study.
Table 1
Demographic and clinical characteristics of the study population (n = 27).
Characteristic Median (range)
Age at ﬁrst seizure 4 months (15 days to 36 months)
Age at start of diet 2.5 years (9 months to 5 years)




Atypical absence 15 (55.5%)
Atonic 7 (25.9%)
Generalized tonic 18 (66.6%)
Infantile spasms 6 (22.2%)
Partial 2 (7.4%)
Generalized tonic clonic 3 (11.1%)
Epilepsy syndrome
Lennox Gastaut syndrome 14 (51.8%)
West syndrome 6 (22.2%)





Development delay 27 (100%)
Cerebral palsy 17 (62.9%)
Vision impairment 5 (18.5%)
Hearing impairment 4 (14.8%)
Feeding difﬁculties 9 (33.3%)
Hyperactivity 6 (22.2%)
a Most children had mixed seizure types.
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Each child underwent detailed history and examination.
Seizure type, frequency, age at onset, perinatal details, family
history, developmental status and treatment history were noted.
Medications were changed to carbohydrate free preparations,
wherever available. Corticosteroids or ACTH were tapered off 2
weeks before starting the diet. The following investigations were
obtained at baseline: electroencephalography (EEG), blood urea,
serum creatinine, liver function tests (serum bilirubin, serum
glutamate oxaloacetate transaminase [SGOT], serum glutamate
pyruvate transaminase [SGPT] and serum albumin), fasting lipid
proﬁle including total cholesterol, serum triglycerides, low density
lipoprotein [LDL], high density lipoprotein [HDL], and very low
density lipoprotein [VLDL] and urinary spot calcium–creatinine
ratios.
2.3. KD initiation
The children were admitted to the hospital for KD initiation
using the non-fasting gradual initiation protocol described by
Bergqvist et al.9 KD was started with a full calorie, ketogenic ratio
(ratio of fat:protein + carbohydrate) by weight of 1:1. This was
built up over a period of 4 days to 3:1 in children younger than 18
months, and 4:1 in children older than 18 months. The recipes
were planned in-house and calculated considering the families and
the child’s preferences and cultural taboos. Diets were based on
Indian recipes and prepared with common locally available foods.
Blood sugar was monitored 8 hourly, and urine ketones were
checked by Dipstick at every void. The child was discharged by the
fourth or ﬁfth day. The AED were continued unchanged.
While the child was hospitalized, training about the calculation
of meals, weighing of foods, and the rationale behind the diet was
re-inforced. Parents were given diet plans and recipes to be made
at home. Each child also received a sugar-free, fat soluble vitamin
supplement and calcium supplementation.
2.4. Follow up
Patients were followed up at 1, 2, 3, 6 months and 1 year after
KD initiation. Seizure frequencywas checked according to parental
reports and seizure diaries. The seizure control was categorized as
seizure free, >90% seizure reduction, 50–90% seizure reduction,
<50% seizure reduction or increase in seizures. Compliance with
the diet was checked by parental records of daily urine ketones
chart. Adverse effects were noted. The biochemical proﬁle
including a fasting lipid proﬁle, and urinary spot calcium–
creatinine ratioswere tested at each follow up visit. Oral potassium
citrate supplementation was started in children with urinary spot
calcium creatinine ratio more than 0.2. EEG was obtained at 3
months, 6 months and 12 months after diet initiation.
2.5. Statistical analysis
Data was analysed using SPSS software version 15. The non-
parametric two way analysis of variance, i.e. Friedman test was
applied to see any change over time for continuous variables. For
categorical tests, Chi square test was applied. The level of
signiﬁcance was taken as 0.05.
3. Results
During the study period, parents of 27 of the 41 children found
eligible for inclusion were willing for trial (Fig. 1). In 14 patients;
the parents were not willing for KD trial. The reasons cited were:
feeling that child would ﬁnd diet too restrictive (6), ﬁnancialconstraints (2), unwilling for hospital admission (2), mother
having too much work at home, and unable to spare time for
weighing and preparation of meals (2), staying far-off and
unwilling for regular follow up (2). Out of the 27 patients included
in the trial, 18 were vegetarian. Apart from those with infantile
spasms, seizure frequency ranged from 5 to 100/day. Most patients
suffered from mixed seizure types (Table 1). All the patients
suffered from generalized epilepsy syndromes: the most fre-
quently encountered types being Lennox-Gastaut syndrome (14),
West syndrome (6) and myoclonic astatic epilepsy (4). In three
patients, the epilepsy syndrome could not be classiﬁed, but the
predominant seizure type was myoclonic. Multiple AED had been
tried (median 5 AED, range 3–11).
KD initiation was well tolerated. The most common side effect
was vomiting, noted in 75% of the patients. No patient developed
Table 2
Seizure frequency on follow up.
Time on diet Number of patients <50% reduction 50–90% reduction >90% reduction Seizure free Increase
3 months 24 7 (25.9%) 9 (33.3%) 4 (14.8%) 3 (11.1%) 1 (3.7%)
6 months 15 2 (7.4%) 7 (25.9%) 2 (7.4%) 4 (14.8%) Nil
12 months 10 Nil 3 (11.1%) 2 (7.4%) 5 (18.5%) Nil
Table 3
Biochemical proﬁle on ketogenic diet.
Baseline (n = 27),
mean [SD]
1 month (n = 27),
mean [SD]
2 months (n = 26),
mean [SD]
3 months (n = 24),
mean [SD]
6 months (n = 15),
mean [SD]
12 months (n = 10),
mean [SD]
p-Value
Blood urea (mg/dl) 21.33 [7.17] 19.66 [4.00] 19.84 [5.14] 19.52 [3.92] 18.13 [2.44] 18.30 [2.86] 0.242
S. creatinine (mg/dl) 0.57 [0.12] 0.58 [0.10] 0.56 [0.11] 0.61 [0.08] 0.62 [0.12] 0.69 [0.09] 0.243
SGOT (IU/l) 42.51 [15.95] 52.07 [34.35] 47.96 [30.48] 51.65 [30.66] 43.53 [17.15] 38.70 [5.71] 0.577
SGPT (IU/l) 26.33 [10.59] 40.62 [28.05] 34.03 [16.43] 39.91 [23.22] 35.00 [15.03] 36.33 [10.23] 0.454
S. Albumin (g/dl) 4.11 [.34] 4.11 [0.42] 4.18 [0.30] 4.08 [0.35] 4.04 [0.33] 3.96 [0.30] 0.0453*
Urine spot cal–creat ratio (mg/dl) 0.09 [0.09] 0.12 [0.07] 0.19 [0.08] 0.12 [0.05] 0.11 [0.08] 0.13 [0.04] 0.035*
* Signiﬁcant.
Fig. 2. Lipid proﬁle in the study population at KD initiation and follow up.
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hypoglycaemia which improved after feeding.
The number of children remaining on KD at 3, 6, and 12months;
and the percentage achieving varying levels of seizure control are
shown in Table 2. Six months after starting KD, 15 of the 27
children (55.5%) were still on the diet. Four children (14.8%) were
seizure free and two (7.4%) had 90% or greater decrease in seizures.
An additional seven children (25.9%) had a 50–90% decrease in
seizures. Thus at 6 months, 13 children (48.1%) of this difﬁcult-to-
control seizure population achieved a >50% decrease in seizures.
At 1 year after initiating KD, 10 of the initial patients (37%)
remained on it. Five (18.5%) were seizure free, and two (7.4%) had a
90% or greater decrease in seizures. An additional three (11.1%)
children had a 50–90% reduction in seizure frequency. Thus, 1 year
after starting KD, 10 children (37%) had achieved a>50% reduction
in seizure.
EEG revealed background improvement in the form of reduced
slowing, better organization or resolution of hypsarrhythmia or its
variants in eight children at 6 months, and seven children at 1 year
after KD initiation. Paroxysmal abnormalities in the form of
reduced or absent polyspikes, reduced multifocal sharp waves and
spikes, reduced generalized spike wave activity and reduced or
absent paroxysmal fast activity was noted in seven children at 6
months and six children at 12 months after starting the diet.
The biochemical proﬁle of the patients at baseline and follow up
is detailed in Table 3. There was no statistically signiﬁcant
difference in blood urea, serum creatinine, SGOT and SGPT. There
was a statistically signiﬁcant fall in serum albumin (p = 0.04) and
increase in spot urinary calcium to creatinine ratio (p = 0.03). The
mean lipid proﬁle parameters at baseline and follow up are shown
in Fig. 2. The change in lipid proﬁle over time was not statistically
signiﬁcant.
Constipation was the most common adverse effect, noted in
nearly three-fourths of the patients. Four children lost weight
during the ﬁrst 3 months after starting KD. This was managed by
increasing the calorie intake. One child developed renal stones.
Two children developed hypo-albuminemia and edema. This
improved on increasing the daily protein allowance. There were no
deaths on the KD during the study period. Three children
developed severe intercurrent infections requiring mechanical
ventilation and ICU stay.
Unsatisfactory seizure control was themost common reason for
discontinuation (11 children). In three children, as described
above, the KD was discontinued because of severe intercurrent
illness requiring mechanical ventilation and PICU stay. In two
children, parents discontinued the KD in less than 3 monthsduration, because of the child’s refusal to eat; despite having 50–
90% seizure control in one child.
4. Discussion
To our knowledge this is the ﬁrst prospective study evaluating
KD in Indian children with refractory epilepsy. Our results are
comparable to previously published studies of KD.1–15 Using
intention-to-treat analysis, at 6 months on the diet, 14.8% were
seizure free, and overall 48.1% had a 50% or greater reduction in
seizures in our study. Our ﬁndings are comparable to the ﬁndings
in a recent systematic review analyzing all studies of KD published
between 1990 and 2005. Twenty-six studies were included in the
review, with a total collective population of 972.16 At 6 months,
15.6% patients had become seizure free while 33.0% were reported
to have greater than 50% reduction in seizure frequency after
commencing the diet.
In the present study, 10 children (37%) remained on KD for 1
year. As intention-to-treat analysis was used, the percentage of
patients who had >50% seizure reduction at 12 months; i.e. 37%,
was lower that at 6 months, i.e. 48.1%. The proportion of patients
continuing KD for 1 year in previous studies has ranged from 7% to
56%.16 Our results are comparable to those studies, where
intention-to-treat analysis has been used to report outcomes.
The long-term status of KD in Indian patients needs to be studied
with large number of patients.
Although Indian diets are traditionally cereal-based and contain
substantially less fat than traditional Western diets, KD was
S. Sharma et al. / Seizure 18 (2009) 446–449 449nonetheless well tolerated. Indigenous recipes, keeping in mind
cultural factors and food preferences (especially vegetarian food)
were designed. Refusal to eat possibly because of unpalatibility
was a cause for discontinuation in only two children. This is
consistentwithmost studies on KD,which have demonstrated that
KD is tolerated if it is effective in controlling seizures.1–5
Age, sex, seizure type and etiology has not been shown to
predict response in previous studies.1–5,10–15 There was no
relationship between age, sex, etiology (cryptogenic versus
symptomatic), or epilepsy syndrome and seizure control in the
present study.
Blood urea, serum creatinine, SGOT and SGPT did not change
signiﬁcantly on the diet. Hassan et al., in a retrospective study did
not ﬁnd any abnormalities in routine biochemical testing when on
KD.4 There was a signiﬁcant fall in mean serum albumin in the
present study. Two patients had developed hypoproteinemia with
pedal edema on the diet, which responded to increasing the
protein intake from 1 g/kg/day to 2 g/kg/day. The recommendation
in classic KD of protein intake of 1 g/kg/day seems to be less in the
context of young Indian children. In childrenwho developed serum
albumin <3.5 g/dl, protein intake was increased to 1.5 g/kg/day.
This increase of protein intake did not worsen the seizure control.
Hypoproteinemia on KD has been described in isolated case
reports,17 but there are no studies with serial follow ups, like ours.
There was a signiﬁcant rise in spot urinary calcium–creatinine
ratio over time. Hypercalciuria occurswith the KD due to increased
bone mineralization with acidosis as well as increased calcium
excretion by the kidney. This leads to an increased risk for renal
stones, which are reported in 3–10% of children on KD. Recently
Sampath et al. evaluated the preventive use of potassium citrate in
children on ketogenic diet in a retrospective cohort study.18 Their
results demonstrated that the use of oral potassium citrate
signiﬁcantly decreased the prevalence of stones (3.2% versus
10%, p = 0.049). The oral potassium citrate supplementation in
children with urinary spot calcium creatinine ratio more than 0.2
in the present study limited the renal calculus prevalence to 3.7%.
The change in lipid proﬁle over time in the present study was
not statistically signiﬁcant. Other authors have also described a
similar trend.12,13 Kwiterovich et al. however found increased lipid
levels on KD.19 In their study, after 6 months, the patients on KD
had signiﬁcantly increasedmean plasma levels of total cholesterol,
LDL, VLDL, and triglycerides. The long-term risks of this
dyslipidemia are not clear.
Constipationwas themost frequent side effect encountered. This
has been theﬁnding inother studies aswell.1–8,10–15Weight loss at3
months was noted in four children. A recent study examining the
effect of KD on growth in 237 children revealed that the rate of
weight gain decreased at 3months, but remained constant for up to
3 years.20 The calorie and protein intake need to be adjusted as per
the weight gain of the child, as we did in our study.
The fact that three children developed severe intercurrent
infections requiring mechanical ventilation and PICU stay is a
cause for concern. Though most studies on KD have reported a few
patients with severe infections or even deaths, these events have
not been considered to be due to KD per se.1–8,10–15 The deaths
have been attributed to the fragile status of these children with
refractory epilepsy, most of whom have severe global develop-
mental delay and co-morbid cerebral palsy; which makes them
more susceptible to serious infection. One study reported impairedneutrophil function in children on KD; however, this ﬁnding has
not been evaluated or reported in further studies.21
5. Conclusion
KD is a feasible, well-tolerated and effective therapeutic option
for young Indian children with refractory epilepsy. Biochemical
proﬁle did not reveal signiﬁcant changes over time, except for
reduced serum albumin and increased spot urinary calcium–
creatinine ratio. However, KD is not without possible side effects
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